Implementing food-based dietary guidelines for - United Nations ...

S114
Taylor SL, Stengard JH, Salomaa V, Vartiainen E, Perola
M, Boerwinkle E, Sing CF. Apolipoprotein E variation at
the sequence haplotype level: Implications for the origin
and maintenance of a major human polymorphism. Am
J Hum Genet 2000;67:881–900.
84. Ordovas JM, Corella D. Nutritional genomics. Annu Rev
Genomics Hum Genet 2004;5:71–118.
85. Ordovas JM. The quest for cardiovascular health in the
genomic era: Nutrigenetics and plasma lipoproteins.
Proc Nutr Soc 2004;63:145–52.
86. Edmonds DK, Lindsay KS, Miller JF, Williamson E,
Wood PJ. Early embryonic mortality in women. Fertil
Steril 1982;38:447–53.
87. Edwards RG. Recent scientific and medical advances
in assisted human conception. Int J Dev Biol 1997;41:
255–62.
88. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes
TK. Hyperhomocysteinemia and recurrent early
pregnancy loss: A meta-analysis. Fertil Steril 2000;74:
1196–9.
89. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas
CM, Eskes TK. Homocysteine and folate levels as risk
factors for recurrent early pregnancy loss. Obstet Gynecol
2000;95:519–24.
90. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers
GH, Eskes TK. Methylenetetrahydrofolate reductase
polymorphism affects the change in homocysteine and
folate concentrations resulting from low dose folic acid
supplementation in women with unexplained recurrent
miscarriages. J Nutr 1998;128:1336–41.
91. Shelnutt KP, Kauwell GP, Gregory JF 3rd, Maneval DR,
Quinlivan EP, Theriaque DW, Henderson GN, Bailey
LB. Methylenetetrahydrofolate reductase 677C→T
polymorphism affects DNA methylation in response
to controlled folate intake in young women. J Nutr
Biochem 2004;15:554–60.
92. Hunt JR, Zeng H. Iron absorption by heterozygous
carriers of the HFE C282Y mutation associated with
hemochromatosis. Am J Clin Nutr 2004;80:924–31.
93. Swanson CA. Iron intake and regulation: Implications
for iron deficiency and iron overload. Alcohol
2003;30:99–102.
94. Moirand R, Guyader D, Mendler MH, Jouanolle AM,
Le Gall JY, David V, Brissot P, Deugnier Y. HFE based
re-evaluation of heterozygous hemochromatosis. Am J
Med Genet 2002;111:356–61.
95. Baier LJ, Hanson RL. Genetic studies of the etiology of
type 2 diabetes in Pima Indians: Hunting for pieces to a
complicated puzzle. Diabetes 2004;53:1181–6.
96. Tseung CW, McMahon LG, Vazquez J, Pohl J, Gregory JF
3rd. Partial amino acid sequence and mRNA analysis of
cytosolic pyridoxine-beta-D-glucoside hydrolase from
porcine intestinal mucosa: Proposed derivation from
the lactase-phlorizin hydrolase gene. Biochem J 2004;
380(pt 1):211–8.
97. Mackey AD, McMahon RJ, Townsend JH, Gregory
JF 3rd. Uptake, hydrolysis, and metabolism of pyridoxine-5’-beta-D-glucoside
in Caco-2 cells. J Nutr
2004;134:842–6.
98. Seifried HE, Anderson DE, Sorkin BC, Costello RB. Free
radicals: The pros and cons of antioxidants. Executive
summary report. J Nutr 2004;134:3143S–63S.
99. Zeisel SH. Antioxidants suppress apoptosis. J Nutr
P. J. Stover
2004;134:3179S–80S.
100. Csete M, Doyle J. Bow ties, metabolism and disease.
Trends Biotechnol 2004;22:446–50.
101. Pennisi E. Evolution of developmental diversity. Evodevo
devotees eye ocular origins and more. Science
2002;296:1010–1.
102. Pasqualetti M, Neun R, Davenne M, Rijli FM. Retinoic
acid rescues inner ear defects in Hoxa1 deficient mice.
Nat Genet 2001;29:34–9.
103. Finnell RH, Spiegelstein O, Wlodarczyk B, Triplett A,
Pogribny IP, Melnyk S, James JS. DNA methylation in
Folbp1 knockout mice supplemented with folic acid
during gestation. J Nutr 2002;132(8 suppl):2457S–61S.
104. Seckl JR, Meaney MJ. Glucocorticoid programming.
Ann NY Acad Sci 2004;1032:63–84.
105. Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid
dehydrogenase type 1—a tissue-specific amplifier of glucocorticoid
action. Endocrinology 2001;142:1371–6.
106. McMillen IC, Robinson JS. Developmental origins of
the metabolic syndrome: Prediction, plasticity, and
programming. Physiol Rev 2005;85:571–633.
107. Seckl JR. Prenatal glucocorticoids and long-term programming.
Eur J Endocrinol 2004;151(suppl 3):U49–62.
108. White PC, Mune T, Agarwal AK. 11 beta-Hydroxysteroid
dehydrogenase and the syndrome of apparent
mineralocorticoid excess. Endocr Rev 1997;18:135–56.
109. Bertram C, Trowern AR, Copin N, Jackson AA,
Whorwood CB. The maternal diet during pregnancy
programs altered expression of the glucocorticoid
receptor and type 2 11beta-hydroxysteroid dehydrogenase:
Potential molecular mechanisms underlying the
programming of hypertension in utero. Endocrinology
2001;142:2841–53.
110. Drake AJ, Walker BR, Seckl JR. Intergenerational consequences
of fetal programming by in utero exposure to
glucocorticoids in rats. Am J Physiol Regul Integr Comp
Physiol 2005;288:R34–8.
111. Gatford KL, Wintour EM, De Blasio MJ, Owens JA,
Dodic M. Differential timing for programming of glucose
homoeostasis, sensitivity to insulin and blood pressure
by in utero exposure to dexamethasone in sheep.
Clin Sci (Lond) 2000;98:553–60.
112. Valera A, Pujol A, Pelegrin M, Bosch F. Transgenic mice
overexpressing phosphoenolpyruvate carboxykinase
develop non-insulin-dependent diabetes mellitus. Proc
Natl Acad Sci USA 1994;91:9151–4.
113. Rosella G, Zajac JD, Kaczmarczyk SJ, Andrikopoulos
S, Proietto J. Impaired suppression of gluconeogenesis
induced by overexpression of a noninsulin-responsive
phosphoenolpyruvate carboxykinase gene. Mol Endocrinol
1993;7:1456–62.
114. Asipu A, Hayward BE, O’Reilly J, Bonthron DT. Properties
of normal and mutant recombinant human ketohexokinases
and implications for the pathogenesis of
essential fructosuria. Diabetes 2003;52:2426–32.
115. Cox TM. The genetic consequences of our sweet tooth.
Nat Rev Genet 2002;3:481–7.
116. Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy:
Tubuloglomerular feedback and renal injury in
African Americans. Kidney Int 2004;65:361–8.
117. Messier W, Stewart CB. Episodic adaptive evolution of
primate lysozymes. Nature 1997;385:151–4.
118. Zhang J, Zhang YP, Rosenberg HF. Adaptive evolution